We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Tool Predicts Lung Cancer Risk from Low-Dose Chest CT Scans

By MedImaging International staff writers
Posted on 16 Jan 2023
Print article
AI tool accurately predicts lung cancer risk for individuals (Photo courtesy of Mass General Cancer Center)
AI tool accurately predicts lung cancer risk for individuals (Photo courtesy of Mass General Cancer Center)

Lung cancer is the leading cause of cancer death in the world. Low-dose chest computed tomography (LDCT) is recommended to screen people in the age group of 50 to 80 years who have a significant history of smoking or who currently smoke. Studies have shown that LDCT screening can reduce the risk of death from lung cancer by up to 24%. However, with the rates of lung cancer rising among non-smokers, there is a need for new strategies to screen and accurately predict lung cancer risk among a wider population. Now, researchers have developed and tested an artificial intelligence (AI) tool that accurately predicts the risk of lung cancer for individuals with or without a significant smoking history based on analysis of LDCT scans from patients.

In order to help improve the efficiency of lung cancer screening and provide individualized assessments, investigators from the Mass General Cancer Center (Boston, MA, US), in collaboration with researchers at the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA), have developed Sybil, a deep-learning model that analyzes scans and predicts lung cancer risk for the next one to six years. In their study, the team validated Sybil using three independent data sets - a set of scans from more than 6,000 NLST participants who Sybil had not previously seen; 8,821 LDCTs from the US; and 12,280 LDCTs from Taiwan. The latter set of scans included people with a range of smoking history, including those who never smoked.

The researchers found that Sybil could accurately predict risk of lung cancer across these sets. The team determined Sybil’s accuracy using Area Under the Curve (AUC), which measures how well a test distinguishes between disease and normal samples and in which 1.0 is considered to be a perfect score. Sybil was able to predict cancer within one year with AUCs of 0.92 for the additional NLST participants, 0.86 for the MGH dataset, and 0.94 for the dataset from Taiwan. Sybil predicted lung cancer within six years with AUCs of 0.75, 0.81, and 0.80, respectively, for the three datasets. The researchers will now begin a prospective clinical trial to test Sybil in the real world and see how it can aid radiologists..

“Sybil requires only one LDCT and does not depend on clinical data or radiologist annotations,” said co-author Florian Fintelmann, MD, of the Department of Radiology, Division of Thoracic Imaging & Intervention at Massachusetts General Hospital. “It was designed to run in real-time in the background of a standard radiology reading station which enables point-of care clinical decision support.”

 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
PACS Workstation
CHILI Web Viewer
New
Brachytherapy Planning System
Oncentra Brachy
New
Wireless Handheld Ultrasound System
TE Air

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.